阿里-SW(09988.HK)續升逾2% 推阿里版ChatGPT「通義千問」
阿里-SW(09988.HK)承上周四(6日)長假期前升2.2%勢頭,今早(11日)高開2.5%,報100.2元。初段曾升3.8%,高見101.5元,現升2.4%,報100.1元,成交1,831萬股,成交額18億元。
2023阿里雲峰會今日在北京舉行。阿里董事會主席兼CEO、阿里雲智能CEO張勇會上表示,阿里所有產品將接入通義千問,進行全面改造。據悉,釘釘、天貓精靈將率先接入通義千問測試,評估認證後正式發布新功能。
阿里巴巴旗下阿里雲較早前宣布,公司自行研發大模型「通義千問」開始邀請測試。現階段該模型主要定向邀請企業使用者進行體驗測試,用戶可通過官網申請,符合條件的用戶可參與體驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.